Methods, devices, and systems for blood flow

US9861410B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9861410-B2
Application numberUS-201615148464-A
CountryUS
Kind codeB2
Filing dateMay 6, 2016
Priority dateMay 6, 2016
Publication dateJan 9, 2018
Grant dateJan 9, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Various exemplary methods, systems, and devices for blood flow are provided. In general, an implant can be configured to be implanted in bone and to delay clotting of blood flowing from the bone. The implant can include an anti-coagulation agent to delay the clotting of the blood. The anti-coagulation agent can be a coating on the implant, can be natural to a material forming the implant, or can be impregnated into a material forming the implant. In an exemplary embodiment, the implant is implanted in a bone in a surgical procedure for securing a soft tissue to bone, such as a rotator cuff repair procedure or an anterior cruciate ligament (ACL) repair procedure.

First claim

Opening claim text (preview).

What is claimed is: 1. A surgical method, comprising: forming a hole in a bone of a patient in a soft tissue repair procedure; implanting an implant in the hole, the implant including an anti-coagulation agent, wherein the implant is a tubular member, and an inner lumen of the tubular member is occluded when the implant is implanted in the hole such that the blood is prevented from flowing through the implanted implant until a selected amount of time has lapsed after completion of the soft tissue repair procedure, and wherein the implant has a suture extending therefrom; and pulling the suture from outside the patient's body and thereby removing a plug from the inner lumen of the tubular member. 2. The method of claim 1 , wherein the implant is made from an energy activated material disposed therein that occludes the inner lumen, and the method further comprises, after the selected amount of time has elapsed, activating the energy activated material by application of energy thereto. 3. The method of claim 1 , wherein the implant includes a retaining member configured to engage the bone in which the implant is implanted to retain the implant within the bone. 4. The method of claim 1 , wherein the implant is bioabsorbable. 5. The method of claim 1 , wherein the implant is not bioabsorbable. 6. The method of claim 1 , wherein the anti-coagulation agent is coated on a surface of the implant. 7. The method of claim 1 , wherein the anti-coagulation agent is impregnated in a material forming the implant. 8. The method of claim 1 , wherein the anti-coagulation agent includes at least one of heparin, heparin sulfate, warfarin, hirudin, hirulog, coumarin, phosphorylcholine, indiandione, antithrombin III, bemiparin, dalteparin, danaparoid, enoxaparin, nadroparin, parnaparin, reviparin, sulodexide, tinzaparin, anticoagulant citrate dextrose solution A (ACD-A), ethylenediaminetetraacetic acid (EDTA), citrate, oxalate, a factor Xa inhibitor, and a thrombin inhibitor. 9. The method of claim 1 , wherein the implant is an anchor, and the anchor has at least one bone-engaging surface feature on an exterior surface thereof that engages the bone to secure the anchor in the hole. 10. The method of claim 1 , further comprising implanting an anchor in the bone at a site a distance away from a site where the implant is implanted, wherein the implant is a tubular member that is not connected to the anchor with any implanted matter. 11. A surgical method, comprising: forming a hole in a bone of a patient in a soft tissue repair procedure; implanting an implant in the hole, the implant including an anti-coagulation agent, wherein the implant is a tubular member, and an inner lumen of the tubular member is occluded when the implant is implanted in the hole such that the blood is prevented from flowing through the implanted implant until a selected amount of time has lapsed after completion of the soft tissue repair procedure, and wherein the implant includes a knitted material that occludes the inner lumen; and pulling the knitted material after the selected amount of time has elapsed to cause the knitted material to unravel. 12. The method of claim 11 , wherein the implant is an anchor, and the anchor has at least one bone-engaging surface feature on an exterior surface thereof that engages the bone to secure the anchor in the hole. 13. The method of claim 11 , further comprising implanting an anchor in the bone at a site a distance away from a site where the implant is implanted, wherein the implant is a tubular member that is not connected to the anchor with any implanted matter. 14. The method of claim 11 , wherein the implant includes a retaining member configured to engage the bone in which the implant is implanted to retain the implant within the bone. 15. The method of claim 11 , wherein the implant is bioabsorbable. 16. The method of claim 11 , wherein the implant is not bioabsorbable. 17. The method of claim 11 , wherein the anti-coagulation agent is coated on a surface of the implant. 18. The method of claim 11 , wherein the anti-coagulation agent is impregnated in a material forming the implant. 19. The method of claim 11 , wherein the anti-coagulation agent includes at least one of heparin, heparin sulfate, warfarin, hirudin, hirulog, coumarin, phosphorylcholine, indiandione, antithrombin III, bemiparin, dalteparin, danaparoid, enoxaparin, nadroparin, parnaparin, reviparin, sulodexide, tinzaparin, anticoagulant citrate dextrose solution A (ACD-A), ethylenediaminetetraacetic acid (EDTA), citrate, oxalate, a factor Xa inhibitor, and a thrombin inhibitor.

Assignees

Inventors

Classifications

  • Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate · CPC title

  • having one single leg, e.g. tacks · CPC title

  • Longitudinal through hole, e.g. suture blocked by a distal suture knot · CPC title

  • snug fit within the anchor · CPC title

  • cannulated, e.g. with a longitudinal through-hole for passage of an instrument · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9861410B2 cover?
Various exemplary methods, systems, and devices for blood flow are provided. In general, an implant can be configured to be implanted in bone and to delay clotting of blood flowing from the bone. The implant can include an anti-coagulation agent to delay the clotting of the blood. The anti-coagulation agent can be a coating on the implant, can be natural to a material forming the implant, or ca…
Who is the assignee on this patent?
Medos Int Sarl
What technology area does this patent fall under?
Primary CPC classification A61B17/0642. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).